JRCT ID: jRCTs042230030
Registered date:02/06/2023
Stereotactic Radiotherapy for Fatal Arrhythmias
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | ventricular tachycardia |
Date of first enrollment | 18/10/2023 |
Target sample size | 3 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Stereotactic radiotherapy for VT origins |
Outcome(s)
Primary Outcome | Treatment safety in the early post-treatment period (within 1 year) |
---|---|
Secondary Outcome | Treatment efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 18age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1) 18 years or older 2) After ICD implantation 3) Patients who have had a recurrence after more than 1 catheter ablation 4) Patients who have experienced 3 or more VT attacks within the past 3 months while taking at least 1 antiarrhythmic drug 5) Patients with fatal arrhythmia that cannot be cured by catheter ablation 6) Patients with no history of irradiation to the cardiac area 7) Patients with written consent from the patient |
Exclude criteria | 1) Heart failure dependent on left ventricular assist device 2) Patients with low probability of survival for more than 6 months due to factors other than VT 3) Cases in which irradiation is contraindicated 4) Patients undergoing maintenance hemodialysis or peritoneal dialysis 5) Patients with heart disease requiring surgical treatment 6) Patients with acute coronary syndrome or acute heart failure requiring hospitalization 7) Patient is at high risk of radiation pneumonitis, such as idiopathic pulmonary fibrosis (IPF) on chest CT 8) Difficult-to-control pericardial effusions or pleural effusions 9) Difficulty in maintaining supine rest for 1 hour. 10) Other illnesses or reasons that make it difficult to perform necessary examinations or follow-up investigations, or for which the principal investigator/participating physician determines that the patient is not suitable to participate in this study. |
Related Information
Primary Sponsor | Kawamura Mariko |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Accuray Japan K.K. |
Secondary ID(s) |
Contact
Public contact | |
Name | Mariko Kawamura |
Address | 65 Tsurumai-cho, Showa-ku, Nagoya city, Aichi pref., Japan Aichi Japan 466-8550 |
Telephone | +81-527442327 |
mkawamura@med.nagoya-u.ac.jp | |
Affiliation | Nagoya University Hospital |
Scientific contact | |
Name | Mariko Kawamura |
Address | 65 Tsurumai-cho, Showa-ku, Nagoya city, Aichi pref., Japan Aichi Japan 466-8550 |
Telephone | +81-527442327 |
mkawamura@med.nagoya-u.ac.jp | |
Affiliation | Nagoya University Hospital |